8
272
N. Aoyagi et al. / Tetrahedron Letters 44 (2003) 8269–8272
4. (a) White, E. L.; Chao, W.-r.; Ross, L. J.; Borhani, D. (6H, m, ArH), 7.62 (1H, t, J=7.5 Hz, ArH), 7.76 (1H, s,
W.; Hobbs, P. D.; Upender, V.; Dawson, M. I. Arch.
Biochem. Biophys. 1999, 50, 25–30; (b) Nicolaou, K. C.;
Boddy, C. N. C.; Br a¨ se, S.; Winssinger, N. Angew.
Chem., Int. Ed. Engl. 1999, 38, 2096–2152; (c) Yim, T. K.;
Ko, K. M. Biochem. Pharmacol. 1999, 57, 77–81; (d)
Chen, D.-F.; Zhang, S.-X.; Lan, X.; Xie, J.-X.; Ke, C.;
Kashiwada, Y.; Zhou, B.-N.; Pei, W.; Cosentino, L. M.;
Lee, K.-H. Bioorg. Med. Chem. 1997, 5, 1715–1723; (e)
Zhiyi, L. K.; Gengtao, L.; Shifu, Z. Cancer Lett. 1996,
OH), 7.91–8.02 (4H, m, ArH), 8.13 (1H, d, J=9.0 Hz,
+
CH); MS (m/z) 297 (M ).
−
1
(±)-2: mp 175–176°C; IR w
(KBr)/cm 1780, 1190
max
1
(CO R); H NMR (CDCl ) l 2.09 (3H, s, CH ), 7.17–
2
3
3
7.33 (4H, m, ArH), 7.43 (1H, d, J=7.0 Hz, ArH), 7.52
2H, q, J=7.0 Hz, ArH), 7.52 (2H, q, J=7.0 Hz, ArH),
.64 (1H, t, J=7.5 Hz, ArH), 7.94 (1H, d, J=8.0 Hz,
(
7
ArH), 7.97–7.99 (3H, m, ArH), 8.03 (1H, d, J=8.5 Hz,
ArH), 8.32 (1H, d, J=9.0 Hz, CH); FABMS (m/z) 340
1
08, 67–72.
. Bringmann, G.; Breuning, M.; Tasler, S. Synthesis 1999,
25–558.
+
(
M+H) .
5
6
1
1
3. (a) Miyaura, N.; Suzuki, A. Chem. Rev. 1995, 95, 2457–
483; (b) Whitaker, C. M.; McMahon, R. J. J. Phys.
5
2
. (a) Piao, G.; Akagi, K.; Shirakawa, H.; Kyotani, M.
Curr. Appl. Phys. 2001, 1, 121–123; (b) Akagi, K.; Piao,
G.; Kaneko, S.; Higuchi, I.; Shirakawa, H.; Kyotani, M.
Synth. Met. 1999, 102, 1406–1409.
. (a) Inagaki, M.; Hiratake, J.; Nishioka, T.; Oda, J. Agric.
Biol. Chem. 1989, 53, 1879–1884; (b) Tamai, Y.; Nakano,
T.; Koike, S.; Kawahara, K.; Miyano, S. Chem. Lett.
Chem. 1996, 100, 1081–1090.
4. LIP from Pseudomonas aeruginosa (Toyobo Co., Ltd.);
Thermomyces lanuginosus (Novo Nordisk Co., Ltd.);
NOVOZYM 435, NOVOZYM 525L and CHIRAZYME
L-2 from Candida antarctica (Novo Nordisk Co., Ltd.);
PPL from Porcine pancreas (Sigma Chemical Co., Ltd.);
CCL from Candida cylindrasea (Sigma Chemical Co.,
Ltd.); PS and AH from Pseudomonas cepacia (Amano
Pharmaceutical Co., Ltd.); AK from Pseudomonas
fluorescene (Amano Pharmaceutical Co., Ltd.); AY from
Candida rugosa (Amano Pharmaceutical Co., Ltd.); OF
and MY from Candida cylindrasea (Meito Sangyo Co.,
Ltd.).
7
1
989, 1135–1136; (c) Furutani, T.; Hatsuda, M.;
Imashiro, R.; Seki, M. Tetrahedron: Asymmetry 1999, 10,
763–4768; (d) Seki, M.; Furutani, T.; Hatsuda, M.;
4
Imashiro, R. Tetrahedron Lett. 2000, 41, 2149–2152.
. Kawahara, K.; Matsumoto, M.; Hashimoto, H.; Miyano,
S. Chem. Lett. 1988, 1163–1164.
8
9
. Meyers, A. I.; Lutomski, K. A. J. Am. Chem. Soc. 1982,
1
1
1
5. Chen, C.-S.; Fujimoto, Y.; Girdaukas, G.; Sih, C. J. J.
Am. Chem. Soc. 1982, 104, 7294–7299.
6. Hanazaki, I.; Akimoto, H. J. Am. Chem. Soc. 1972, 94,
1
04, 879–881.
1
0. Fetizon, M.; Golfier, M.; Mourgues, P.; Louis, J.-M. In
Organic Syntheses by Oxidation with Metal Compounds;
Mijs, W. J.; de Jonge, C. R. H. I., Eds.; Plenum Press:
New York, 1986; pp. 503–567.
8
75–878.
7. Liquid lipase (15 g) and sucrose (9.0 g) were dissolved in
0 mM Tris–HCl buffer (360 mL, pH 7.8) at 0°C. Celite
51 g) was added to the enzyme solution. The mixture
2
(
1
1. (a) Aoyagi, N.; Izumi, T. Tetrahedron Lett. 2002, 43,
5
529–5531; (b) Aoyagi, N.; Kawauchi, S.; Izumi, T.
was vigorously stirred at 30°C for 1 h, the solvent was
removed in vacuo. The residue was dried at room tempera-
ture, yielding immobilized lipase.
Tetrahedron Lett. 2003, 44, 5609–5612.
2. (±)-1: mp 155–157°C; IR wmax (KBr)/cm 3300 (OH); H
−
1
1
1
NMR (CDCl ) l 7.20 (2H, d, J=7.5 Hz, ArH), 7.25–7.51
3